Innovating Works

MEDRI

Desconocido
Mostrando 1 al 20 de 22 resultados
HORUS: Health Outcomes from Raised Urban Settings SVEUCILISTE U RIJECI MEDICINSKI FAKULTET participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 NCDs, especially diabetes and cardiovascular diseases (CVDs), are the leading causes of morbidity and mortality worldwide. CVDs kill more pe...
2023-11-13 - 2026-11-30 | Financiado
Virus RePro IEL: Reprogramming of IELs at the intestinal epithelial barrier during virus infection SVEUCILISTE U RIJECI MEDICINSKI FAKULTET tramitó un H2020: H2020-MSCA-IF-2020 Intestinal epithelial resident CD8+ T lymphocytes, such as intraepithelial lymphocytes (IELs), are located at epithelial barriers. They play...
2021-04-08 - 2024-02-28 | Financiado
VALUECARE: VALUE BASED METHODOLOGY FOR INTEGRATED CARE SUPPORTED BY ICT SVEUCILISTE U RIJECI MEDICINSKI FAKULTET participó en un H2020: H2020-SC1-DTH-2018-2020 Healthy ageing along with independent living have become key challenges for Europe as countries are experiencing growth in the number of old...
2019-10-28 - 2024-09-30 | Financiado
GLIOVACC: Augmenting and broadening T cell responses to glioblastoma therapeutic vaccine platform based on H... SVEUCILISTE U RIJECI MEDICINSKI FAKULTET tramitó un H2020: ERC-2018-PoC The development of an effective vaccine against human cancers is of tremendous importance. Glioblastoma multiforme (GBM) is the most maligna...
2018-11-15 - 2020-07-31 | Financiado
PIXEL: Port IoT for Environmental Leverage SVEUCILISTE U RIJECI MEDICINSKI FAKULTET participó en un H2020: H2020-EE-2016-2017 Ports are a great example of heterogeneous information hubs. Multiple stakeholders operate inside and outside them with different motivation...
2018-04-24 - 2021-09-30 | Financiado
OLEUM: Advanced solutions for assuring the overall authenticity and quality of olive oil SVEUCILISTE U RIJECI MEDICINSKI FAKULTET participó en un H2020: H2020-SFS-2014-2015 The OLEUM project will generate innovative, more effective and harmonized analytical solutions to detect and fight the most common and emerg...
2016-07-08 - 2021-02-28 | Financiado
GLYCOVAX: A training network for the rational design of the next generation of well defined glycoconjugate vac... SVEUCILISTE U RIJECI MEDICINSKI FAKULTET participó en un H2020: H2020-MSCA-ITN-2015 GLYCOVAX is a network for the education of promising young scientists who will learn how to rationally design a next generation of well-defi...
2015-08-11 - 2019-10-31 | Financiado
DRIVE-AB: DRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE SVEUCILISTE U RIJECI MEDICINSKI FAKULTET participó en un FP6: Antimicrobial resistance (AMR) is widespread. Its global human and economic burden is tremendous and increasing annually. Yet today only a f...
2014-10-01 - 2017-12-31 | Financiado
NKG2D in T-cells: Memory Control The role of NKG2D and the T cell receptor in memory T cell biology SVEUCILISTE U RIJECI MEDICINSKI FAKULTET tramitó un FP7: Despite our advances in medical sciences, infectious diseases such as HIV and Hepatitis C remain an important health problem for our society...
Financiado
TRANSMEDRI: Upgrading the capacities for research in translational medicine at the Faculty of Medicine Universit... SVEUCILISTE U RIJECI MEDICINSKI FAKULTET tramitó un FP7: One of the major impediments for development of the biomedical research at the University of Rijeka has been the lack of a competitive resea...
Financiado
CAPRI2010: The Center for Antibody Production Rijeka Upgrading the Central Research and Service Infrastructure... SVEUCILISTE U RIJECI MEDICINSKI FAKULTET tramitó un FP7: "The Center for Proteomics was established at the Medical Faculty, University of Rijeka in 2006 with focus on monoclonal antibodies (mAb) de...
Financiado
STADVINN: Strengthening adaptive immunity via innate immunity enhancing the CD8 T cell response by using the... SVEUCILISTE U RIJECI MEDICINSKI FAKULTET tramitó un FP7: CD8+ T cells play a key role in the control of infections by intracellular pathogens. Recently, several top-notch studies provided ample evi...
Financiado
DRIVE-AB: DRIVING RE INVESTMENT IN R D AND RESPONSIBLE ANTIBIOTIC USE SVEUCILISTE U RIJECI MEDICINSKI FAKULTET participó en un FP7: Antimicrobial resistance (AMR) is widespread. Its global human and economic burden is tremendous and increasing annually. Yet today only a f...
Financiado
HTP-GLYCOMET: Methods for high throughput glycoproteomic analysis SVEUCILISTE U RIJECI MEDICINSKI FAKULTET participó en un FP7: The main aim of the HTP-GlycoMet proposal is to develop technologies, which will enable high-throughput analysis of glycosylation of individ...
Financiado
INFLA-CARE: Understanding inflammation associated tumorigenesis for the rational design of novel anti cancer the... SVEUCILISTE U RIJECI MEDICINSKI FAKULTET participó en un FP7: Epidemiological and experimental evidence supports a link between chronic inflammation and cancer and indicates a role for inflammatory cell...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.